Biesogen Partners with Warsaw Genomics: Excellence in Genetic Diagnosis with International Support

At Biesogen, we are dedicated to providing genetic diagnosis solutions of the highest standard.

As such, we are very pleased with our strategic alliance with Warsaw Genomics, a leader in the field of genetics that shares our commitment to excellence and innovation. This collaboration allows us to provide our clients with access to advanced genetic testing, backed by rigorous international quality certifications and constant participation in external quality assessment programs, ensuring accurate, reliable, up-to-date, and relevant results for various areas of health.

View Products

Focus on Warsaw Genomics

Warsaw Genomics is recognized for its dedication to the research and development of cutting-edge genetic testing. Their commitment to quality is reflected in the rigorous international certifications they have obtained. These certifications are a testament to their compliance with the highest industry standards in terms of:

Test accuracy and reliability

Warsaw Genomics’ laboratory processes are audited externally to ensure the accuracy and reproducibility of the results.

Quality Management

They implement quality management systems that comply with international regulations, ensuring traceability and security of samples and data.

Staff competence

They have a team of highly trained scientists and technicians with extensive experience in genetics.

Warsaw Genomics is distinguished by its constant pursuit of excellence in the development and application of state-of-the-art genetic testing. Its commitment to quality is manifested through the following accreditations and participations:

  • SO 9001:2015: This international standard defines the requirements for an effective quality management system (QMS), ensuring the organization’s ability to consistently provide products and services that meet customer needs and regulatory requirements. Warsaw Genomics’ ISO 9001:2015 certification confirms its focus on continuous improvement and customer satisfaction in all its processes.
  • ISO/IEC 27001:2013: This international standard focuses on information security, setting out the requirements for an information security management system (ISMS). Warsaw Genomics’ ISO/IEC 27001:2013 certification demonstrates its commitment to protecting the confidentiality, integrity, and availability of its customers’ information, a fundamental aspect in the handling of sensitive genetic data.
  • Successful participation in the College of American Pathologists (CAP) 2021 NGS-A program: CAP, a leading global organization in pathology and laboratory medicine, endorses Warsaw Genomics’ competence in performing highly complex genetic testing through its NGS-A 2021 External Quality Assessment (EQA) program for germline next-generation sequencing (NGS). The excellent results obtained, with 90% in the evaluation of correct variants and 100% in specificity, demonstrate the high level of accuracy and reliability of its tests.
  • Participation in the European Molecular Genetics Quality Network (EMQN) External Quality Assessment (EQA) programme in 2020: Warsaw Genomics’ participation in EMQN’s EQA schemes for ovarian cancer (germline and somatic variants) in 2020, with satisfactory results in genotyping and clinical agreement, demonstrates its continued commitment to quality and continuous improvement in the field of genetic diagnostics. EMQN is a UKAS accredited not-for-profit organisation that provides EQA schemes for genetic testing laboratories.
  • Participation in INSTAND’s external quality assessment for the detection of the SARS-CoV-2 virus genome in 2020: The successful participation in this program by INSTAND, a renowned German organization in the field of external quality assessments for medical laboratories, demonstrates Warsaw Genomics’ ability to perform accurate and reliable molecular diagnostic tests, even in health emergency situations such as the COVID-19 pandemic.
  • Participation in the QCMD 2022 SARS-CoV-2 EQA program: Participation in the QCMD 2022 SARS-CoV-2 EQA (External Quality Assessment) program further reinforces Warsaw Genomics’ commitment to quality in SARS-CoV-2 testing, demonstrating its ability to maintain high standards even in an ever-evolving field. QCMD is a UKAS accredited proficiency testing provider.

Certificates

These certifications and participations, granted by prestigious bodies such as the Polskie Rejestru Statków (PRS), the College of American Pathologists (CAP), the European Molecular Genetics Quality Network (EMQN), INSTAND and QCMD, are a clear testament to Warsaw Genomics’ compliance with the highest industry standards in:

  • Test accuracy and reliability: EQA’s rigorous laboratory processes and constant participation in programs ensure the accuracy and reproducibility of results, as well as constant updating with best practices.
  • Quality Management: Quality management systems are implemented that comply with international regulations, ensuring traceability and security of samples and data.
  • Information security: Protecting sensitive patient information is a priority, backed by a robust ISMS.
  • Staff competence: A team of highly trained scientists and technicians with extensive experience in genetics ensures quality at every stage of the process.
  • Capacity to respond to health emergencies and adapt to new diagnostic needs: Participation in specific EQA programs, such as INSTAND and QCMD for SARS-CoV-2, demonstrates Warsaw Genomics’ adaptability and responsiveness to new diagnostic needs.

Benefits of the alliance for Biesogen customers

Thanks to this alliance with Warsaw Genomics, at Biesogen we can offer you:

Access to a wide range of genetic tests

From predisposition tests to carrier studies and prenatal diagnosis, with the highest quality, reliability and the support of international organizations.

Reliable and accurate results

Backed by ISO 9001:2015 and ISO/IEC 27001:2013 certifications and successful participation in external quality assessment programs such as CAP’s NGS-A 2021, EMQN schemes, and INSTAND and QCMD assessments for SARS-CoV-2.

Professional genetic counseling

A team of experts will guide you to understand the test results and make informed decisions about your health.

Find out how the partnership between Biesogen and Warsaw Genomics can benefit you.

Visit our genetic testing section or contact us for more information.

Contact by WhatsApp

or through our Form

* Fields with (*) are required

Google reCaptcha: Invalid site key.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.